IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-36334-1.html
   My bibliography  Save this article

Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

Author

Listed:
  • Jenniffer Linares

    (Hospital del Mar Medical Research Institute (IMIM)
    Catalan Institute of Oncology (ICO))

  • Anna Sallent-Aragay

    (Hospital del Mar Medical Research Institute (IMIM))

  • Jordi Badia-Ramentol

    (Hospital del Mar Medical Research Institute (IMIM))

  • Alba Recort-Bascuas

    (Hospital del Mar Medical Research Institute (IMIM))

  • Ana Méndez

    (University of Oviedo)

  • Noemí Manero-Rupérez

    (Hospital del Mar Medical Research Institute (IMIM))

  • Daniele Lo Re

    (The Barcelona Institute of Science and Technology (BIST))

  • Elisa I. Rivas

    (Hospital del Mar Medical Research Institute (IMIM))

  • Marc Guiu

    (The Barcelona Institute of Science and Technology (BIST))

  • Melissa Zwick

    (Hospital del Mar Medical Research Institute (IMIM))

  • Mar Iglesias

    (Hospital del Mar Medical Research Institute (IMIM)
    Centro de Investigación Biomédica en Red de Cáncer (CIBERONC))

  • Carolina Martinez-Ciarpaglini

    (INCLIVA Biomedical Research Institute, University of Valencia)

  • Noelia Tarazona

    (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
    INCLIVA Biomedical Research Institute, University of Valencia)

  • Monica Varese

    (The Barcelona Institute of Science and Technology (BIST))

  • Xavier Hernando-Momblona

    (The Barcelona Institute of Science and Technology (BIST)
    Centro de Investigación Biomédica en Red de Cáncer (CIBERONC))

  • Adrià Cañellas-Socias

    (The Barcelona Institute of Science and Technology (BIST)
    Centro de Investigación Biomédica en Red de Cáncer (CIBERONC))

  • Mayra Orrillo

    (Medical Oncology Department, Hospital del Mar)

  • Marta Garrido

    (Hospital del Mar Medical Research Institute (IMIM))

  • Nadia Saoudi

    (Vall d’Hebron Hospital Campus and Institute of Oncology (VHIO))

  • Elena Elez

    (Vall d’Hebron Hospital Campus and Institute of Oncology (VHIO))

  • Pilar Navarro

    (Institute of Biomedical Research of Barcelona (IIBB-CSIC)
    Institut d’Investigacions Biomèdiques August Pi Sunyer (IDIBAPS)
    Unidad Asociada IIBB-CSIC)

  • Josep Tabernero

    (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
    Vall d’Hebron Hospital Campus and Institute of Oncology (VHIO))

  • Roger R. Gomis

    (The Barcelona Institute of Science and Technology (BIST)
    Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
    Institució Catalana de Recerca i Estudis Avançats (ICREA))

  • Eduard Batlle

    (The Barcelona Institute of Science and Technology (BIST)
    Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
    Institució Catalana de Recerca i Estudis Avançats (ICREA))

  • Jorge Pisonero

    (University of Oviedo)

  • Andres Cervantes

    (Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
    INCLIVA Biomedical Research Institute, University of Valencia)

  • Clara Montagut

    (Hospital del Mar Medical Research Institute (IMIM)
    Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
    Medical Oncology Department, Hospital del Mar)

  • Alexandre Calon

    (Hospital del Mar Medical Research Institute (IMIM))

Abstract

A substantial proportion of cancer patients do not benefit from platinum-based chemotherapy (CT) due to the emergence of drug resistance. Here, we apply elemental imaging to the mapping of CT biodistribution after therapy in residual colorectal cancer and achieve a comprehensive analysis of the genetic program induced by oxaliplatin-based CT in the tumor microenvironment. We show that oxaliplatin is largely retained by cancer-associated fibroblasts (CAFs) long time after the treatment ceased. We determine that CT accumulation in CAFs intensifies TGF-beta activity, leading to the production of multiple factors enhancing cancer aggressiveness. We establish periostin as a stromal marker of chemotherapeutic activity intrinsically upregulated in consensus molecular subtype 4 (CMS4) tumors and highly expressed before and/or after treatment in patients unresponsive to therapy. Collectively, our study underscores the ability of CT-retaining CAFs to support cancer progression and resistance to treatment.

Suggested Citation

  • Jenniffer Linares & Anna Sallent-Aragay & Jordi Badia-Ramentol & Alba Recort-Bascuas & Ana Méndez & Noemí Manero-Rupérez & Daniele Lo Re & Elisa I. Rivas & Marc Guiu & Melissa Zwick & Mar Iglesias & C, 2023. "Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36334-1
    DOI: 10.1038/s41467-023-36334-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-36334-1
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-36334-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Sebastian Schafer & Sivakumar Viswanathan & Anissa A. Widjaja & Wei-Wen Lim & Aida Moreno-Moral & Daniel M. DeLaughter & Benjamin Ng & Giannino Patone & Kingsley Chow & Ester Khin & Jessie Tan & Sonia, 2017. "IL-11 is a crucial determinant of cardiovascular fibrosis," Nature, Nature, vol. 552(7683), pages 110-115, December.
    2. Elisa I. Rivas & Jenniffer Linares & Melissa Zwick & Andrea Gómez-Llonin & Marc Guiu & Anna Labernadie & Jordi Badia-Ramentol & Anna Lladó & Lídia Bardia & Iván Pérez-Núñez & Carolina Martínez-Ciarpag, 2022. "Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    3. Paula D. Bos & Xiang H.-F. Zhang & Cristina Nadal & Weiping Shu & Roger R. Gomis & Don X. Nguyen & Andy J. Minn & Marc J. van de Vijver & William L. Gerald & John A. Foekens & Joan Massagué, 2009. "Genes that mediate breast cancer metastasis to the brain," Nature, Nature, vol. 459(7249), pages 1005-1009, June.
    4. David A. Barbie & Pablo Tamayo & Jesse S. Boehm & So Young Kim & Susan E. Moody & Ian F. Dunn & Anna C. Schinzel & Peter Sandy & Etienne Meylan & Claudia Scholl & Stefan Fröhling & Edmond M. Chan & Ma, 2009. "Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1," Nature, Nature, vol. 462(7269), pages 108-112, November.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Shirong Cao & Yu Pan & Andrew S. Terker & Juan Pablo Arroyo Ornelas & Yinqiu Wang & Jiaqi Tang & Aolei Niu & Sarah Abu Kar & Mengdi Jiang & Wentian Luo & Xinyu Dong & Xiaofeng Fan & Suwan Wang & Matth, 2023. "Epidermal growth factor receptor activation is essential for kidney fibrosis development," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    2. Bieke Decaesteker & Amber Louwagie & Siebe Loontiens & Fanny De Vloed & Sarah-Lee Bekaert & Juliette Roels & Suzanne Vanhauwaert & Sara De Brouwer & Ellen Sanders & Alla Berezovskaya & Geertrui Deneck, 2023. "SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    3. Qingnan Liang & Yuefan Huang & Shan He & Ken Chen, 2023. "Pathway centric analysis for single-cell RNA-seq and spatial transcriptomics data with GSDensity," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    4. Yue Wang & Dhamotharan Pattarayan & Haozhe Huang & Yueshan Zhao & Sihan Li & Yifei Wang & Min Zhang & Song Li & Da Yang, 2024. "Systematic investigation of chemo-immunotherapy synergism to shift anti-PD-1 resistance in cancer," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    5. Yan Li & Chen Xu & Bing Wang & Fujiang Xu & Fahan Ma & Yuanyuan Qu & Dongxian Jiang & Kai Li & Jinwen Feng & Sha Tian & Xiaohui Wu & Yunzhi Wang & Yang Liu & Zhaoyu Qin & Yalan Liu & Jing Qin & Qi Son, 2022. "Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies," Nature Communications, Nature, vol. 13(1), pages 1-26, December.
    6. Fei Wu & Huixun Du & Eliah Overbey & JangKeun Kim & Priya Makhijani & Nicolas Martin & Chad A. Lerner & Khiem Nguyen & Jordan Baechle & Taylor R. Valentino & Matias Fuentealba & Juliet M. Bartleson & , 2024. "Single-cell analysis identifies conserved features of immune dysfunction in simulated microgravity and spaceflight," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
    7. Weili Ma & Maria Cecília Oliveira-Nunes & Ke Xu & Andrew Kossenkov & Benjamin C. Reiner & Richard C. Crist & James Hayden & Qing Chen, 2023. "Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    8. Shen Zhao & Wu Zhuang & Baohui Han & Zhengbo Song & Wei Guo & Feng Luo & Lin Wu & Yi Hu & Huijuan Wang & Xiaorong Dong & Da Jiang & Mingxia Wang & Liyun Miao & Qian Wang & Junping Zhang & Zhenming Fu , 2023. "Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    9. Augusto Faria Andrade & Alva Annett & Elham Karimi & Danai Georgia Topouza & Morteza Rezanejad & Yitong Liu & Michael McNicholas & Eduardo G. Gonzalez Santiago & Dhana Llivichuzhca-Loja & Arne Gehlhaa, 2024. "Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    10. Riley D. Metcalfe & Eric Hanssen & Ka Yee Fung & Kaheina Aizel & Clara C. Kosasih & Courtney O. Zlatic & Larissa Doughty & Craig J. Morton & Andrew P. Leis & Michael W. Parker & Paul R. Gooley & Tracy, 2023. "Structures of the interleukin 11 signalling complex reveal gp130 dynamics and the inhibitory mechanism of a cytokine variant," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    11. Davide Bernareggi & Qi Xie & Briana C. Prager & Jiyoung Yun & Luisjesus S. Cruz & Timothy V. Pham & William Kim & Xiqing Lee & Michael Coffey & Cristina Zalfa & Pardis Azmoon & Huang Zhu & Pablo Tamay, 2022. "CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    12. Wanzun Lin & Li Chen & Haojiong Zhang & Xianxin Qiu & Qingting Huang & Fangzhu Wan & Ziyu Le & Shikai Geng & Anlan Zhang & Sufang Qiu & Long Chen & Lin Kong & Jiade J. Lu, 2023. "Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    13. Kang Wang & Ioannis Zerdes & Henrik J. Johansson & Dhifaf Sarhan & Yizhe Sun & Dimitris C. Kanellis & Emmanouil G. Sifakis & Artur Mezheyeuski & Xingrong Liu & Niklas Loman & Ingrid Hedenfalk & Jonas , 2024. "Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer," Nature Communications, Nature, vol. 15(1), pages 1-24, December.
    14. Brian D. Lehmann & Antonio Colaprico & Tiago C. Silva & Jianjiao Chen & Hanbing An & Yuguang Ban & Hanchen Huang & Lily Wang & Jamaal L. James & Justin M. Balko & Paula I. Gonzalez-Ericsson & Melinda , 2021. "Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    15. Eduardo Gomez-Bañuelos & Yikai Yu & Jessica Li & Kevin S. Cashman & Merlin Paz & Maria Isabel Trejo-Zambrano & Regina Bugrovsky & Youliang Wang & Asiya Seema Chida & Cheryl A. Sherman-Baust & Dylan P., 2023. "Affinity maturation generates pathogenic antibodies with dual reactivity to DNase1L3 and dsDNA in systemic lupus erythematosus," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    16. Anissa A. Widjaja & Sivakumar Viswanathan & Shamini G. Shekeran & Eleonora Adami & Wei-Wen Lim & Sonia Chothani & Jessie Tan & Joyce Wei Ting Goh & Hui Mei Chen & Sze Yun Lim & Carine M. Boustany-Kari, 2022. "Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    17. Wonbin Park & Jae-Seong Lee & Ge Gao & Byoung Soo Kim & Dong-Woo Cho, 2023. "3D bioprinted multilayered cerebrovascular conduits to study cancer extravasation mechanism related with vascular geometry," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    18. Qilin Zhang & Ziyan Xu & Rui Han & Yunzhi Wang & Zhen Ye & Jiajun Zhu & Yixin Cai & Fan Zhang & Jiangyan Zhao & Boyuan Yao & Zhaoyu Qin & Nidan Qiao & Ruofan Huang & Jinwen Feng & Yongfei Wang & Wenti, 2024. "Proteogenomic characterization of skull-base chordoma," Nature Communications, Nature, vol. 15(1), pages 1-32, December.
    19. Zhenmei Yao & Ning Xu & Guoguo Shang & Haixing Wang & Hui Tao & Yunzhi Wang & Zhaoyu Qin & Subei Tan & Jinwen Feng & Jiajun Zhu & Fahan Ma & Sha Tian & Qiao Zhang & Yuanyuan Qu & Jun Hou & Jianming Gu, 2023. "Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ," Nature Communications, Nature, vol. 14(1), pages 1-25, December.
    20. Su Yin Lim & Elena Shklovskaya & Jenny H. Lee & Bernadette Pedersen & Ashleigh Stewart & Zizhen Ming & Mal Irvine & Brindha Shivalingam & Robyn P. M. Saw & Alexander M. Menzies & Matteo S. Carlino & R, 2023. "The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma," Nature Communications, Nature, vol. 14(1), pages 1-18, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36334-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.